Prosensa Holding B.V. IPO Research Information

Prosensa Holding B.V. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Prosensa Holding B.V., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Prosensa Holding B.V.	RNA - NASDAQ	$11.00-$13.00	$13.00	$20.00	6 million	6/28/2013
Underwriter(s): J.P. Morgan, Citigroup, Leerink Swann
Co-Manager(s): Wedbush PacGrow Life Sciences, KBC Securities, Trout Capital
Industry: Health Care
Filing(s): Filed 2013-05-24

Prosensa Holding B.V. Quote & Chart - Click for current quote - RNA

About Prosensa Holding B.V. (adapted from Prosensa Holding B.V. prospectus):
They are an innovative biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.